Recombinant Human CCDC6 Protein, N-His-SUMO

Description of Recombinant Human CCDC6 Protein, N-His-SUMO

Introduction

Recombinant Human CCDC6 protein is a crucial protein that plays a significant role in various cellular processes. It is a recombinant protein, meaning it is produced through genetic engineering techniques, making it highly pure and specific. In this article, we will discuss the structure, activity, and applications of this important protein.

Structure of Recombinant Human CCDC6 Protein

The CCDC6 protein is composed of 654 amino acids and has a molecular weight of approximately 74 kDa. It belongs to the coiled-coil domain-containing protein family and contains a highly conserved coiled-coil domain, which is responsible for its structural stability and function.

The recombinant human CCDC6 protein is produced in a host cell, typically E. coli, and undergoes post-translational modifications, such as glycosylation, to ensure proper folding and functionality. The resulting protein is highly pure and has a similar structure to the native human CCDC6 protein.

Activity of Recombinant Human CCDC6 Protein

The CCDC6 protein has been shown to have various activities in different cellular processes. One of its main functions is to act as a tumor suppressor. It does so by regulating cell growth, differentiation, and apoptosis. Mutations in the CCDC6 gene have been linked to various types of cancers, including thyroid cancer and lung adenocarcinoma.

Additionally, CCDC6 has been found to play a role in DNA damage response and repair, as well as in the regulation of the cell cycle. It interacts with other proteins, such as p53 and BRCA1, to carry out these functions.

Applications of Recombinant Human CCDC6 Protein

The recombinant human CCDC6 protein has various applications in both research and clinical settings. One of its most significant uses is in cancer research. By studying the structure and activity of CCDC6, scientists can gain a better understanding of its role in tumorigenesis and potentially develop targeted therapies for cancer treatment.

Moreover, recombinant human CCDC6 protein can be used as an antigen in diagnostic tests for certain types of cancers. Antibodies against CCDC6 can be used to detect its expression levels in patient samples, aiding in the diagnosis and prognosis of cancer.

Furthermore, the protein can also be used in drug discovery and development. Its tumor suppressor activity makes it a potential target for anti-cancer drugs, and its interactions with other proteins make it a valuable tool for studying protein-protein interactions and developing new therapies.

Conclusion

In summary, recombinant human CCDC6 protein is a crucial protein with a well-defined structure and various activities in cellular processes. Its role as a tumor suppressor and its potential applications in cancer research and therapy make it an essential protein for further study. With advancements in genetic engineering techniques, the production of highly pure and specific recombinant CCDC6 protein has become more accessible, paving the way for more in-depth research and potential clinical applications.